| |
|
|
| |
 |
 |
 |
 |
Contact Us
Please mail photos, text, audio cassette or video as applicable to |
PPH Cure Foundation
1735 Connecticut Ave., NW
3rd. Floor
Washington, DC 20009 |
 |
|
| |
|
|
|
|
Texas Biotechnology Corporation (Houston, TX) has commenced a small study of their
Endothelin - A selective inhibitor in pulmonary hypertension patients. Another company,
Actelion (Switzerland) may be starting a similar study of their Endothelin A/B inhibitor
in pulmonary hypertension patients. Other pharmaceutical companies may be commencing
large studies of Endothelin inhibitors for congestive heart disease.
|
|
|
Home